Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

Graham Ogg photo

Professor Graham Ogg is one of 11 University of Oxford biomedical and health scientists elected to the Academy of Medical Sciences Fellowship.

Professor Ogg has led ground-breaking research into COVID-19 immune responses, as well as continuing with his research into the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination. He is currently collaborating with colleagues in Sri Lanka to compare COVID-19 responses in different populations, to uncover the role of 'background' immunity to virus strains already in circulation. He has also co-led a study demonstrating that individuals with mild COVID-19 had a different pattern of T cell response when compared to those with more severe infection.

Professor Ogg was also the first recipient of the now annual RDM awards for excellent supervision, with members of his team commending him for 'his incredible enthusiasm and optimism', and for always having time to meet people and provide prompt and excellent feedback. 

Professor Ogg said "I am delighted to have received such a prestigious honour, which really reflects a group effort with my terrific team in the MRC Human Immunology Unit."

Many congratulations to Professor Ogg!

Read the full story on the Oxford University website

Similar stories

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.

New model for infant leukaemia announced

The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the Patel Group sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

$2m awarded to explore the role of ancestry in vaccine response

The Lymph nodE single-cell Genomics AnCestrY (LEGACY) Network will create an ethnically diverse single-cell atlas of the response to commonly used vaccines such as flu vaccines with a focus on responses in lymph nodes.

Joe Frost wins 2021 RDM graduate prize

Many congratulations to Dr Frost.